Literature DB >> 30139770

Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosis.

Stephen M Humphries1, Jeffrey J Swigris2, Kevin K Brown2, Matthew Strand3, Qi Gong4, John S Sundy4, Ganesh Raghu5, Marvin I Schwarz6, Kevin R Flaherty7, Rohit Sood8, Thomas G O'Riordan4, David A Lynch1.   

Abstract

We evaluated performance characteristics and estimated the minimal clinically important difference (MCID) of data-driven texture analysis (DTA), a high-resolution computed tomography (HRCT)-derived measurement of lung fibrosis, in subjects with idiopathic pulmonary fibrosis (IPF).The study population included 141 subjects with IPF from two interventional clinical trials who had both baseline and nominal 54- or 60-week follow-up HRCT. DTA scores were computed and compared with forced vital capacity (FVC), diffusing capacity of the lung for carbon monoxide, distance covered during a 6-min walk test and St George's Respiratory Questionnaire scores to assess the method's reliability, validity and responsiveness. Anchor- and distribution-based methods were used to estimate its MCID.DTA had acceptable reliability in subjects appearing stable according to anchor variables at follow-up. Correlations between the DTA score and other clinical measurements at baseline were moderate to weak and in the hypothesised directions. Acceptable responsiveness was demonstrated by moderate to weak correlations (in the directions hypothesised) between changes in the DTA score and changes in other parameters. Using FVC as an anchor, MCID was estimated to be 3.4%.Quantification of lung fibrosis extent on HRCT using DTA is reliable, valid and responsive, and an increase of ∼3.4% represents a clinically important change.
Copyright ©ERS 2018.

Entities:  

Mesh:

Year:  2018        PMID: 30139770     DOI: 10.1183/13993003.01384-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.

Authors:  Margaret L Salisbury; Justin C Hewlett; Guixiao Ding; Cheryl R Markin; Katrina Douglas; Wendi Mason; Adam Guttentag; John A Phillips; Joy D Cogan; Sara Reiss; Daphne B Mitchell; Pingsheng Wu; Lisa R Young; Lisa H Lancaster; James E Loyd; Stephen M Humphries; David A Lynch; Jonathan A Kropski; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

Review 2.  Approaching Clinical Trials in Childhood Interstitial Lung Disease and Pediatric Pulmonary Fibrosis.

Authors:  Robin R Deterding; Emily M DeBoer; Michal J Cidon; Terry E Robinson; David Warburton; Gail H Deutsch; Lisa R Young
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

3.  Radiologic evaluation of compensatory lung growth using computed tomography by comparison with histological data from a large animal model.

Authors:  Keiji Ohata; Toyofumi F Chen-Yoshikawa; Masatsugu Hamaji; Takeshi Kubo; Tatsuo Nakamura; Hiroshi Date
Journal:  Sci Rep       Date:  2022-02-15       Impact factor: 4.379

4.  Deep Learning-based Approach for Automated Assessment of Interstitial Lung Disease in Systemic Sclerosis on CT Images.

Authors:  Guillaume Chassagnon; Maria Vakalopoulou; Alexis Régent; Evangelia I Zacharaki; Galit Aviram; Charlotte Martin; Rafael Marini; Norbert Bus; Naïm Jerjir; Arsène Mekinian; Thông Hua-Huy; Laurence Monnier-Cholley; Nouria Benmostefa; Luc Mouthon; Anh-Tuan Dinh-Xuan; Nikos Paragios; Marie-Pierre Revel
Journal:  Radiol Artif Intell       Date:  2020-07-15

5.  The evolution of computer-based analysis of high-resolution CT of the chest in patients with IPF.

Authors:  Lucio Calandriello; Simon Lf Walsh
Journal:  Br J Radiol       Date:  2021-04-21       Impact factor: 3.629

6.  Subclinical Interstitial Lung Abnormalities: Lumping and Splitting Revisited.

Authors:  Simon L F Walsh; Luca Richeldi
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

7.  The Fibrosis Burden of Systemic Sclerosis.

Authors:  Michael P Keane
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

8.  Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?

Authors:  Nada Taha; Dejanira D'Amato; Karishma Hosein; Tiziana Ranalli; Gianluigi Sergiacomi; Maurizio Zompatori; Marco Mura
Journal:  Respir Res       Date:  2020-05-19

9.  Meta-analysis of the radiological and clinical features of Usual Interstitial Pneumonia (UIP) and Nonspecific Interstitial Pneumonia (NSIP).

Authors:  Lukas Ebner; Stergios Christodoulidis; Thomai Stathopoulou; Thomas Geiser; Odile Stalder; Andreas Limacher; Johannes T Heverhagen; Stavroula G Mougiakakou; Andreas Christe
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

10.  Mediastinal Lymphadenopathy in Interstitial Lung Disease. Time to Be Counted.

Authors:  Simon L F Walsh
Journal:  Am J Respir Crit Care Med       Date:  2019-03-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.